Chiara Perugini

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study

A. Costanzo, A. Narcisi, M. Valenti, 2022, Dermatology and Therapy.

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study

A. Costanzo, A. Narcisi, M. Valenti, 2022, Dermatology and Therapy.

Dupilumab for the Treatment of Atopic Dermatitis of the Elderly: a Real-Life 52-Week Experience.

A. Costanzo, A. Narcisi, P. Facheris, 2023, The Journal of dermatological treatment.